[1]
Likhar, R.V. and Joshi, S. 2025. Recent development of heterocyclic scaffolds as EGFR kinase inhibitors in cancer. Current Issues in Pharmacy and Medical Sciences. 38, 2 (May 2025), 112–121. DOI:https://doi.org/10.12923/cipms-2025-0018.